Pharmaceutical Technology on MSN
BMS reports flat revenue growth for full-year 2025
The company projects 2026 revenues between $46.0bn and $47.5bn, with non-GAAP EPS ranging from $6.05 to $6.35.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results